Pfizer (PFE) Current Deferred Revenue (2020 - 2025)
Pfizer (PFE) reported Current Deferred Revenue of $784 million for Q4 2025, down 48.1% from $1.51 billion a year earlier and down 15.2% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Current Deferred Revenue (2020 - 2025) Analysis & Trends
Dating back to Q4 2020, Pfizer's Current Deferred Revenue record includes 19 quarters.
- Current Deferred Revenue has a five-year compound annual growth rate of -6.8% (FY2020 to FY2025).
- By year, Current Deferred Revenue came in at $1.51 billion in FY2024 (-44.0%), $2.7 billion in FY2023 (+7.1%), $2.52 billion in FY2022 (-17.8%) and $3.07 billion in FY2021 (+175.6%).
- The Q4 2025 figure ranks as the lowest quarterly Current Deferred Revenue in data going back to Q4 2020.
- Year over year, Current Deferred Revenue has now declined in each of the last five quarters, with an average decline of 17.4% over the last seven quarters.
- The high point for year-over-year Current Deferred Revenue in five years was Q4 2021 (growth of 175.6%); the low point was Q2 2023 (a decline of 66.2%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $924 million (Q3 2025), $1.12 billion (Q2 2025) and $1.01 billion (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 128.38 Bn | 100.39 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 784.00 Mn |
| Sep 28, 2025 | 924.00 Mn |
| Jun 29, 2025 | 1.12 Bn |
| Mar 30, 2025 | 1.01 Bn |
| Dec 31, 2024 | 1.51 Bn |
| Sep 29, 2024 | 2.02 Bn |
| Jun 30, 2024 | 2.53 Bn |
| Mar 31, 2024 | 2.50 Bn |
| Dec 31, 2023 | 2.70 Bn |
| Jul 2, 2023 | 1.29 Bn |
| Apr 2, 2023 | 1.75 Bn |
| Dec 31, 2022 | 2.52 Bn |
| Jul 3, 2022 | 3.80 Bn |
| Apr 3, 2022 | 3.11 Bn |
| Dec 31, 2021 | 3.07 Bn |
| Oct 3, 2021 | 3.53 Bn |
| Jul 4, 2021 | 4.29 Bn |
| Apr 4, 2021 | 2.05 Bn |
| Dec 31, 2020 | 1.11 Bn |
API Access
Pfizer Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();